HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

HIV/AIDS prevalence updates for India and China

According to health officials the number of new HIV/AIDS cases in China is soaring. The rates are especially high among college students and older men. The Chinese Center for Disease Control and Prevention issued figures showing 48,000 new cases in China in 2011, the official Xinhua news agency said.

30 Nov 2011

With HIV and unaware of it: CDC report

Over the years diagnosis with HIV/AIDS has ceased to become a death sentence. However a new Centers for Disease Prevention and Control (CDC) report says only one in four Americans with AIDS has the virus under control with adequate medication. Figures also show that about 16,000 people die from the disease annually, and the number of new infections each year in the U.S. has held steady at about 50,000 in recent years.

30 Nov 2011

Political will, strong leadership from U.S. needed to end AIDS epidemic

"This Thursday's commemoration of World AIDS Day marks a potential turning point in the fight against a global epidemic that has yet to be arrested," a Detroit Free Press editorial states.

30 Nov 2011

Global leaders plan next steps at Harvard on World AIDS Day

Thirty years, 30 million deaths and 60 million infections after HIV appeared, medical researchers now have the tools to halt the deadly epidemic. "We have the weapons to win the war against AIDS," says Richard Marlink, M.D., Executive Director of the AIDS Initiative at the Harvard School of Public Health. "It is time to take what we have learned to turn the epidemic around and end AIDS."

30 Nov 2011

Study: Abstinence-only education does not reduce teen pregnancy rates

States that prescribe abstinence-only sex education programs in public schools have significantly higher teenage pregnancy and birth rates than states with more comprehensive sex education programs, researchers from the University of Georgia have determined.

30 Nov 2011

State roundup: No Mass. insurance mandate referendum

If you chafe against the Massachusetts requirement that you have health insurance, sorry but you won't have a chance to vote against it - not in the next election, anyway. Backers of a ballot measure to repeal the state's insurance mandate sent out an email last week saying they had failed to gather the needed signatures.

30 Nov 2011

AIDS 2012 conference to be held in Washington

Registration, abstract and programme activity submissions for the XIX International AIDS Conference (AIDS 2012), to be held from 22 to 27 July 2012 in Washington, D.C., open December 1 online at www.aids2012.org.

30 Nov 2011

Experts available to discuss on HIV/AIDS prevention at Penn Nursing

Experts in HIV/AIDS prevention at the University of Pennsylvania School of Nursing are available to talk with media for stories on World AIDS Day, which is on December 1.

30 Nov 2011

Cases of two AIDS patients renew hope of AIDS cure for many scientists, New York Times reports

The New York Times profiles two AIDS patients whose cases "suggest to many scientists that curing AIDS may be achievable," according to the newspaper. "One man, the so-called Berlin patient, apparently has cleared his HIV infection, albeit by arduous bone marrow transplants," and the other, "a 50-year-old man in Trenton, N.J., underwent a far less difficult gene therapy procedure. While he was not cured, his body was able to briefly control the virus after he stopped taking the usual antiviral drugs, something that is highly unusual," the newspaper writes.

29 Nov 2011

New trends in HIV/AIDS prevalence

According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.

29 Nov 2011

Testing of vaginal gel for HIV prevention halted after interim results showed no difference from placebo

Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.

29 Nov 2011

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - has stopped testing the gel.

29 Nov 2011

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

The National Institutes of Health (NIH) has awarded $3.2 million to a team of preeminent engineering, chemistry, and biology researchers to develop a highly efficient system of generating nucleic acid molecules, called aptamers.

29 Nov 2011

Tenofovir gel no more effective than placebo gel in preventing HIV

An independent review of the VOICE study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the Microbicide Trials Network, determined that tenofovir gel was no more effective than placebo gel in preventing HIV.

28 Nov 2011

Healthy snacks can aid weight-loss efforts

Women dieters who grab a snack between breakfast and lunch lose less weight compared to those who abstain from a mid-morning snack, according to a study led by researchers at Fred Hutchinson Cancer Research Center.

28 Nov 2011

Mass immunization with cervical cancer vaccine switched to a more effective variety

Cervarix is currently offered to girls aged 12 and 13 years to protect against strains of the sexually transmitted human papillomavirus (HPV), which causes most cases of cancer of the cervix, the neck of the womb. Cervarix was picked by the Labour government for the first four-year phase of the NHS programme in 2008 because it offered ‘best overall value’ and more than five million doses have been given.

27 Nov 2011

Funds for AIDS, tuberculosis and malaria dry up

A global fund organization against three killer diseases says it has run out of money to pay for new grant programs for the next two years. An official with the Global Fund to Fight AIDS, Tuberculosis and Malaria said Thursday that it has been forced to cease giving new grants until 2014 because of global economic woes brought on by debt crises in the U.S. and Europe.

27 Nov 2011

Sub-Saharan African countries lose billions of dollars due to migration of doctors

Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.

24 Nov 2011

IPS reports on child poverty in Lesotho

"The triple threat of HIV, poverty and food insecurity is increasingly exposing children to abuse, exploitation and other human rights violations" in Lesotho, Inter Press Service reports in an article examining child poverty in the small southern African country.

24 Nov 2011

NIH-led study advances HIV vaccine research

HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus. The antibody binding site, called the V1/V2 region, represents a suitable HIV vaccine target, according to the scientists who conducted the study. In addition, their research reveals the detailed structure of the V1/V2 region, the last part of the virus surface to be visualized at the atomic level.

24 Nov 2011